Early Administration of Heparin at FMC for PPCI of STEMI Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Heparin is the first choice of anticoagulation drug for primary PCI of STEMI patients. However, the priority of use of hepairn in first medical contact or in Cathlab has not yet studied. Previous study revealed early use of antithrombotic drugs could improve patient\'s survival. Here we supposed that use of heparin at first medical contact could increase the TIMI flow 3 grade ratio in STEMI patients and improve patient\'s survival and/or reduce MACE rather than in Cathlab.
Epistemonikos ID: 7f671465ab165af00c079465d9124231b04fdd13
First added on: May 13, 2024